Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR). - Tanaka A; Vaduganathan M; Imai T; Okada Y; Sonoda S; Torimoto K; Suwa S; Teragawa H; Miyazono M; Fukuda M; Yonezu K; Takahashi N; et al. (Cardiovascular diabetology, 2025)